Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride almost fully depletes allopregnanolone in rat brains and enhances 20α-DHP, but doesn't change 3α-DHP levels.

Estrogen deficiency can reduce the enzyme activity needed to activate vitamin D.

Mutations in the hHb6 gene cause the hair disorder monilethrix.

Early diagnosis and treatment of haemochromatosis are crucial for reversing organ damage and improving fertility.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Specific keratin gene mutations can cause monilethrix.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

New peptide biomaterials based on RADA16-I hydrogel can improve wound healing and could be used for tissue engineering.

The compound 16 from the Merremia peltata plant could potentially be a good treatment for hair loss (alopecia) due to its strong activity and favorable skin absorption.

Individuals with this condition often develop male traits and identities at puberty despite being raised as females.

Finasteride improves hidradenitis suppurativa but not for child-bearing women.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

Finasteride is effective and safe for treating hidradenitis suppurativa in both adults and some younger patients.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

21-hydroxylase deficiency causes hormone imbalances leading to various symptoms, and diagnosis involves clinical and genetic tests.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

HDAC inhibitors like Vorinostat and Entinostat may encourage hair regrowth and could be new treatments for hair loss conditions.

Naringenin and Hesperetin may help hair grow and protect hair cells from damage.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

Certain genetic variants impair enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Two new gene mutations cause a rare hair disorder.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

Finasteride crystals are held together by hydrogen bonds and weak interactions, forming synthon pseudopolymorphs.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.